Perjeta, also known as pertuzumab, represents a important advancement in treating HER2-positive breast cancer. The medication works by blocking a specific pathway on helps cancer cells proliferate. In contrast to some alternative HER2-targeted therapies, pertuzumab avoids directly block the HER2 … Read More